3 Stocks Pushing The Real Estate Industry Lower

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

All three major indices are trading up today with the Dow Jones Industrial Average ( ^DJI) trading up 22 points (0.1%) at 16,756 as of Friday, June 13, 2014, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,558 issues advancing vs. 1,369 declining with 183 unchanged.

The Real Estate industry currently sits up 0.1% versus the S&P 500, which is up 0.2%. A company within the industry that fell today was Altisource Portfolio Solutions ( ASPS), up 1.9%. Top gainers within the industry include E-House China Holdings ( EJ), up 4.2%, Chesapeake Lodging ( CHSP), up 3.2%, Retail Opportunity Investments ( ROIC), up 2.4%, Redwood ( RWT), up 2.3% and Colony Financial ( CLNY), up 2.2%.

TheStreet would like to highlight 3 stocks pushing the industry lower today:

3. Retail Properties of America ( RPAI) is one of the companies pushing the Real Estate industry lower today. As of noon trading, Retail Properties of America is down $0.16 (-1.1%) to $15.00 on light volume. Thus far, 472,526 shares of Retail Properties of America exchanged hands as compared to its average daily volume of 1.3 million shares. The stock has ranged in price between $14.95-$15.16 after having opened the day at $15.16 as compared to the previous trading day's close of $15.16.

Inland Western Retail Real Estate Trust, Inc. is a real estate investment trust. It engages in acquisition, development and management of properties. The trust invests in the real estate markets of United States. Retail Properties of America has a market cap of $3.6 billion and is part of the financial sector. Shares are up 19.2% year-to-date as of the close of trading on Thursday. Currently there are 4 analysts that rate Retail Properties of America a buy, no analysts rate it a sell, and none rate it a hold.

TheStreet Ratings rates Retail Properties of America as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, good cash flow from operations and compelling growth in net income. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity and poor profit margins. Get the full Retail Properties of America Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, Douglas Emmett ( DEI) is down $0.22 (-0.8%) to $28.10 on light volume. Thus far, 147,528 shares of Douglas Emmett exchanged hands as compared to its average daily volume of 734,700 shares. The stock has ranged in price between $28.02-$28.35 after having opened the day at $28.35 as compared to the previous trading day's close of $28.32.

Douglas Emmett, Inc., a real estate investment trust, owns and operates office and multifamily properties in California and Hawaii. As of December 31, 2007, the company's office portfolio consisted of 48 properties and multifamily portfolio consisted of 9 properties. Douglas Emmett has a market cap of $4.0 billion and is part of the financial sector. Shares are up 21.6% year-to-date as of the close of trading on Thursday. Currently there are 3 analysts that rate Douglas Emmett a buy, 3 analysts rate it a sell, and 7 rate it a hold.

TheStreet Ratings rates Douglas Emmett as a hold. The company's strengths can be seen in multiple areas, such as its increase in stock price during the past year, growth in earnings per share and revenue growth. However, as a counter to these strengths, we find that the company's profit margins have been poor overall. Get the full Douglas Emmett Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Omega Healthcare Investors ( OHI) is down $0.54 (-1.5%) to $35.25 on heavy volume. Thus far, 1.2 million shares of Omega Healthcare Investors exchanged hands as compared to its average daily volume of 1.0 million shares. The stock has ranged in price between $35.08-$35.85 after having opened the day at $35.83 as compared to the previous trading day's close of $35.79.

Omega Healthcare Investors, Inc. is a real estate investment firm. The firm invests in the real estate markets of United States. It invests in healthcare facilities, primarily in long-term healthcare facilities in order to create its portfolio. Omega Healthcare Investors, Inc. Omega Healthcare Investors has a market cap of $4.6 billion and is part of the financial sector. Shares are up 20.1% year-to-date as of the close of trading on Thursday. Currently there is 1 analyst that rates Omega Healthcare Investors a buy, 2 analysts rate it a sell, and 3 rate it a hold.

TheStreet Ratings rates Omega Healthcare Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, impressive record of earnings per share growth, compelling growth in net income and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full Omega Healthcare Investors Ratings Report now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the real estate industry could consider iShares Dow Jones US Real Estate ( IYR) while those bearish on the real estate industry could consider ProShares Short Real Estate Fund ( REK).

null

More from Markets

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing

Cramer and His Team Stick to Their Disciplines -- Even When It's Disappointing